Context Therapeutics Inc. · NASDAQ:CNTX
Great Point Partners LLC reported a 6.25% stake in Context Therapeutics Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Great Point Partners LLC reported a 6.25% stake in Context Therapeutics Inc., 4,683,711 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 6.25%
- Shares
- 4,683,711
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Great Point Partners, LLC | 6.25% | 4,683,711 |
| Dr. Jeffrey R. Jay, M.D. | 6.25% | 4,683,711 |
| Ms. Lillian Nordahl | 6.25% | 4,683,711 |
Source
Related
- Context Therapeutics Inc.
- Great Point Partners LLC
- Context Therapeutics Inc. shareholders
- Schedule 13G/A · Great Point Partners LLC · May 15, 2026
- Schedule 13G/A · Great Point Partners LLC · Feb 17, 2026
- Schedule 13G/A · Great Point Partners LLC · Nov 14, 2025
- Schedule 13G/A · Great Point Partners LLC · Aug 14, 2025
- Schedule 13G/A · Great Point Partners LLC · May 15, 2025
- Schedule 13G/A · Mpm Bioimpact LLC · Aug 14, 2026
- Schedule 13G/A · Blue Owl Capital Holdings LP · Aug 12, 2026
- Schedule 13G/A · Octagon Capital Advisors LP · Jul 31, 2026
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026
- Schedule 13G · Octagon Capital Advisors LP · May 14, 2026